USD
$0.00
(0.00%
)At Close (As of Sep 5, 2025)
$671.87M
Market Cap
-
P/E Ratio
-1.66
EPS
$23.56
52 Week High
$14.57
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $107M |
Total Revenue | $283M |
Cost Of Revenue | $176M |
Costof Goods And Services Sold | $176M |
Operating Income | -$74M |
Selling General And Administrative | $88M |
Research And Development | $49M |
Operating Expenses | $181M |
Investment Income Net | - |
Net Interest Income | $31M |
Interest Income | $31M |
Interest Expense | $170K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $25M |
Income Before Tax | -$52M |
Income Tax Expense | -$8.1M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$44M |
Comprehensive Income Net Of Tax | - |
Ebit | -$74M |
Ebitda | -$49M |
Net Income | -$43M |
Field | Value (USD) |
---|---|
Total Assets | $1.2B |
Total Current Assets | $354M |
Cash And Cash Equivalents At Carrying Value | $55M |
Cash And Short Term Investments | $55M |
Inventory | $8.4M |
Current Net Receivables | $69M |
Total Non Current Assets | $866M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $135M |
Intangible Assets Excluding Goodwill | $135M |
Goodwill | $22M |
Investments | - |
Long Term Investments | $570M |
Short Term Investments | $203M |
Other Current Assets | $30M |
Other Non Current Assets | - |
Total Liabilities | $91M |
Total Current Liabilities | $73M |
Current Accounts Payable | $18M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $412K |
Total Non Current Liabilities | $18M |
Capital Lease Obligations | $5.6M |
Long Term Debt | $2.5M |
Current Long Term Debt | $412K |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $9.2M |
Other Current Liabilities | $24M |
Other Non Current Liabilities | $4.9M |
Total Shareholder Equity | $1.1B |
Treasury Stock | - |
Retained Earnings | $590M |
Common Stock | $3K |
Common Stock Shares Outstanding | $30M |
Field | Value (USD) |
---|---|
Operating Cashflow | $21M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $25M |
Capital Expenditures | $40M |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$58M |
Cashflow From Financing | -$4.8M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$3.1M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$44M |
Field | Value (USD) |
---|---|
Gross Profit | $107M |
Total Revenue | $283M |
Cost Of Revenue | $176M |
Costof Goods And Services Sold | $176M |
Operating Income | -$74M |
Selling General And Administrative | $88M |
Research And Development | $49M |
Operating Expenses | $181M |
Investment Income Net | - |
Net Interest Income | $31M |
Interest Income | $31M |
Interest Expense | $170K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $25M |
Income Before Tax | -$52M |
Income Tax Expense | -$8.1M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$44M |
Comprehensive Income Net Of Tax | - |
Ebit | -$74M |
Ebitda | -$49M |
Net Income | -$43M |
Sector: HEALTHCARE
Industry: DIAGNOSTICS & RESEARCH
Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. The company is headquartered in Temple City, California.